Rapid advances have revolutionized the treatment of multiple myeloma, providing better disease control and prolonging ...

England is the first country in the world to make GSK's anti-BCMA drug Blenrep available to patients with the haematological cancer multiple myeloma, in the latest stage of the medicine's renaissance.